β³ Fetching live dividend data...
Home βΊ Calculator βΊ HNGZY Dividend Calculator 2026
Hangzhou Tigermed Consulting Co., Ltd Β· OTC
Price: $4.45 Β· Annual div: $0.01/share Β· Frequency: quarterly Β· Payout ratio: 50% Β· Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in HNGZY β $10.03M in 10 years Β· $181.76/month
Hangzhou Tigermed Consulting Co., Ltd, together with its subsidiaries, provides contract research organization services in the People's Republic of China and internationally. The company offers clinical trial operation services, such as clinical pharmacology, registration and regulatory affairs, scientific affairs, medical translation, pharmacovigilance, real-world research, third-party auditing and training, etc. for innovative drugs, generic drugs, and medical devices, as well as supporting services directly related to clinical trials, including clinical operation, clinical trials, and clinical trials management. It also provides clinical trial related and laboratory services in the drug development process comprising data management and statistical analysis, clinical trial site management, subject recruitment, medical imaging, and laboratory services. In addition, the company offers preclinical development services, including medicinal chemistry, compound screening, DMPK, safety and toxicology, bioanalytical, and formulation research and development services; and clinical development services, such as medical writing, clinical monitoring, regulatory affairs, data management and statistical analysis, decentralized clinical trials, clinical development strategy, site management, medical device/in vitro diagnostics, multi-region clinical trial, and vaccine clinical trial services. Further, it provides medical imaging, pharmacovigilance, medical translation, quality assurance, GMP and medical device consulting, central laboratories, functional services, recruitment management, EDC cloud-based system, and remote follow-up center services; and post-marketing clinical research solutions, such as site identification and selection, central monitoring, project team management, vendor management, and SAS project management services. Hangzhou Tigermed Consulting Co., Ltd was incorporated in 2004 and is headquartered in Hangzhou, the People's Republic of China.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. Β· Privacy Policy
Ready to invest? Open HNGZY position with:
Real after-tax yield depends on where you live and how you hold HNGZY.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| πΊπΈ Roth IRA / 401k | 0% | 0.29% | -2.51% | $29 / yr |
| πΊπΈ US Taxable (15%) β | 15% | 0.25% | -2.55% | $25 / yr |
| πΊπΈ US Taxable (20%) | 20% | 0.23% | -2.57% | $23 / yr |
| π¬π§ UK ISA | 0% | 0.29% | -2.51% | $29 / yr |
| π¬π§ UK Taxable | 8.75% | 0.26% | -2.54% | $26 / yr |
| π¨π¦ TFSA | 0% | 0.29% | -2.51% | $29 / yr |
| π¨π¦ CA Taxable | 25% | 0.22% | -2.58% | $22 / yr |
| π¦πΊ Super (pension) | 15% | 0.25% | -2.55% | $25 / yr |
| π¦πΊ AU Taxable | 30% | 0.20% | -2.60% | $20 / yr |
| π©πͺ DE Taxable | 26.375% | 0.21% | -2.59% | $21 / yr |
| π«π· FR Taxable | 30% | 0.20% | -2.60% | $20 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $0.01/share/yr Β· πΊπΈ US Taxable (15%) Β· static projection (no growth assumed).
HNGZY pays quarterly β 4 times per year. Next ex-div: TBD.
How HNGZY compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024β2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for HNGZY sourced from FMP /financial-growth endpoint β real data, not estimates.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores β lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the HNGZY dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer β
Hangzhou Tigermed Consulting Co., Ltd (HNGZY) is currently trading at $4.45, 65% below its 52-week high. The current dividend yield is 0.29% based on an annual payout of $0.01 per share.
Hangzhou Tigermed Consulting Co., Ltd (HNGZY) is a healthcare stock currently trading at $4.45 with a dividend yield of 0.29%. The company pays an annual dividend of $0.01 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings. Over the past 5 years, HNGZY has grown its dividend at a compound annual rate of 53.8%.
Auto-generated from live market data. For educational purposes only β not financial advice.
News aggregated from public sources via Finnhub & RSS. For informational purposes only.
Real users. No sign-up required to leave a review.
βFinally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.β
βI've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly β $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.β
βReally solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.β
βAs someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.β
βThe Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.β
Reviews reflect users' personal experiences. Not financial advice.
Leave a review βIf DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
β±οΈ Takes 30 seconds Β· No signup Β· Free forever